Details for: JAMP CLINDAMYCIN
Company: JAMP PHARMA CORPORATION
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02483734 | JAMP CLINDAMYCIN | CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) | 150 MG | CAPSULE | ORAL |
| 02483742 | JAMP CLINDAMYCIN | CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) | 300 MG | CAPSULE | ORAL |
Consumer Information
This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.
What the medication is used for
JAMP Clindamycin is used:
- To treat serious infections caused by germs.
- To help prevent serious infections during and after surgery.
What it does
JAMP Clindamycin prevents the growth of germs (bacteria) causing your infection.
When it should not be used
- You are allergic (hypersensitive) to
- Clindamycin
- Lincomycin
- Other ingredients in the product (see list of non-medicinal ingredients)
You should not take JAMP Cinacalcet Tablets if you are hypersensitive (allergic) to any of the ingredients in the tablet
You should not take JAMP Cinacalcet Tablets if your blood calcium level is below the normal range.
What the medicinal ingredient is
Clindamycin hydrochloride.
What the non-medicinal ingredients are
cornstarch, lactose, magnesium stearate, talc and titanium dioxide.
What dosage form it comes in
150 mg and 300 mg capsules
Warnings and precautions
To help avoid side effects and ensure proper use, talk to your healthcare professional before you take JAMP Clindamycin. Talk about any health conditions or problems you may have, including if:
- You have a history of intestinal disorders such as colitis (inflammation of the colon), or inflammatory bowel disease.
- You have diarrhea or usually get diarrhea when you take antibiotics or have ever suffered from problems with your stomach or intestines (e.g. bowel disease, colitis).
- You suffer from problems with your kidneys or liver.
- You have glucose-6-phosphate dehydrogenase (G-6-PD) deficiency and taking primaquine. You need to have routine blood tests while taking JAMP Clindamycin with primaquine to monitor for potential blood cell changes.
- You are pregnant or planning to become pregnant. Clindamycin passes to the human fetus.
- You are breastfeeding or planning to breastfeed. Clindamycin is passed to the infant through human breast milk. Because of the potential for serious adverse reactions in nursing infants, clindamycin should not be taken by nursing mothers.
- You have intolerance to some milk sugars. JAMP Clindamycin capsules contain lactose.
Other warnings you should know about:
Long term use of JAMP Clindamycin
If you have to take JAMP Clindamycin for a long time, your doctor may arrange regular liver, kidney and blood tests. Do not miss these check-ups with your doctor. Long term use can also make you more likely to get other infections that do not respond to JAMP Clindamycin treatment.
Taking JAMP Clindamycin with primaquine
Patients with G-6-PD deficiency taking the combination of clindamycin and primaquine should have routine blood examinations during therapy with primaquine to monitor for potential blood cell changes.
REMEMBER: This medication is for YOU. Never give it to others. It may harm them even if their symptoms are the same as yours.
Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.
Interactions with this medication
- Erythromycin (an antibiotic)
- Rifampin (an antibiotic)
- Muscle relaxants used for operations
- Aminoglycosides (a class of antibiotics)
- Primaquine (antimalarial)
- St. John’s Wort (Hypericum perforatum)
Tell your doctor if you are taking or being administered any other topical or oral medication, including erythromycin or neuromuscular blocking agents.
Proper use of this medication
Your doctor will assess for your child’s ability to swallow JAMP Clindamycin capsules. If the child is unable to reliably swallow a capsule, JAMP Clindamycin capsule should not be used. Your doctor will recommend a suitable dosage form for your child.
Take your medicine (or give the medicine to your child) as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
The capsules should be taken with a full glass of water to avoid throat irritation. The capsules can be taken with or without food.
Usual dose:
Treatment of infection:
Adult Dose
150 mg to 450 mg by mouth every 6 hours depending on the severity of infection.
Child dose (for children weighing ≥ 40 pounds (18.2 kg) and able to swallow):
One of the following dosage ranges should be selected depending on the severity of the infection:
- 8-12 mg/kg/day (4-6 mg/lb/day)
- 13-16 mg/kg/day (6.5-8 mg/lb/day)
- 17-25 mg/kg/day (8.5-12.5 mg/lb/day)
| Severity of the infection | Mild | Moderate | Severe |
|---|---|---|---|
| Weight in pounds (weight in kg) | 4-6 mg/lb/day (8-12 mg/kg/day) | 6.5-8 mg/lb/day (13-16 mg/kg/day) | 8.5-12.5 mg/lb/day (17-25 mg/kg/day) |
| 22-40 (10- 18.2 kg) | * | * | * |
| >40-55 (>18.2-25 kg) | * | * | 150 mg q. 8h |
| >55-75 (>25-34 kg) | * | 150 mg q. 8h | 150 mg q. 6h |
| >75-100 (34-45.5 kg) | 150 mg q. 8h | 150 mg q. 6h | 300 mg q. 8h |
| >100 (>45.5 kg) use adult dosage | 150 mg q. 6h | 300 mg q. 6h | 450 mg q. 6h |
*other appropriate dosage form may be used
Keep taking this medicine for the full time of treatment, even if you (or your child) begin to feel better after a few days.
Prevention of infection (patients undergoing surgery):
Adult dose:
300 mg by mouth at 1 hour before procedure; then 150 mg at 6 hours after the first dose.
Child dose (for children weighing ≥ 40 pounds (18.2 kg) and able to swallow):
10 mg per kg by mouth at 1 hour before procedure; then 5 mg/kg at 6 hours after the first dose.
If you stop taking JAMP Clindamycin
If you stop taking the medicine too soon your infection may come back again or get worse. Do
not stop taking JAMP Clindamycin unless your doctor tells you to.
If you have any further questions on how to take this product, ask your doctor or pharmacist.
Overdose:
If you think you have taken too much JAMP Clindamycin, contact your healthcare professional, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.
Missed Dose:
If you missed a dose of this medication, take it as soon as you remember. This will help to keep a constant amount of medication in your blood. But, if it is almost time for your next dose, skip the missed dose and continue with your next scheduled dose. Do not take two doses at the same time.
Side effects and what to do about them
JAMP Clindamycin can cause side effects such as:
- skin reddening, rash, itching, hives
- feeling sick, vomiting, diarrhea, stomach pain
- sore throat, throat sores
- low red blood cells (anemia) with symptoms such as bruising, bleeding
- low white blood cells (neutropenia) which can lead to more infections
- vaginal infection or vaginitis (inflamed vagina)
Contact your doctor immediately if the following happens:
- You have a severe allergic reaction with symptoms such as:
- sudden wheeziness
- difficulty in breathing
- swelling of eyelids, face or lips
- rash or itching (especially affecting the whole body)
- Blistering and peeling of large areas of skin
- Fever
- Cough
- Feeling unwell
- Swelling of the gums, tongue or lips
- You have liver problems with symptoms such as:
- yellowing of the skin and whites of the eyes (jaundice).
- You have Clostridium difficile colitis (bowel inflammation) with symptoms such as:
- severe, persistent watery or bloody diarrhea (watery or bloody) with or without
- abdominal pain
- nausea
- fever
- vomiting
This may happen months after the last dose of medication. If this occurs, stop taking the medication and contact your doctor right away.
| Symptom / effect | Talk with your healthcare professional Only if severe | Talk with your healthcare professional In all cases | Stop taking drug and get immediate medical help |
|---|---|---|---|
| VERY COMMON | |||
| Liver problem | ✔ | ✔ | |
| COMMON | |||
| Diarrhea | ✔ | ||
| Rash | ✔ | ||
| RARE | |||
| Nausea, abdominal pain | ✔ | ||
| Vomiting | ✔ | ||
| Skin reactions : itching | ✔ | ||
| Signs of a severe allergic reaction such as sudden wheeziness, difficulty in breathing, swelling of eyelids, face or lips, rash or itching (especially affecting the whole body) | ✔ | ||
| NOT KNOWN | |||
| Clostridium difficile colitis (bowel inflammation) with symptoms such as severe or persistent diarrhea, abdominal pain, nausea and vomiting. | ✔ | ||
If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your health care professional.
How to store
Keep in a safe place out of the reach and sight of children.
Store at room temperature (15°C to 30°C) in tightly closed container, away from heat and direct
light. Protect from moisture. Do not store in the fridge or freezer.
Do not store in the bathroom as moisture and heat can cause damage.
Reporting side effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
- Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/healthcanada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
- Calling toll-free at 1-866-234-2345.
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.
More information
- Talk to your healthcare professional
- Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (http://hc-sc.gc.ca/indexeng.php) or by calling JAMP Pharma Corporation at 1-866-399-9091.
This leaflet was prepared by
JAMP Pharma Corporation
Last revised: December 10, 2018